Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate

Prostate

Volumn 40, Issue 1, 1999, Pages 14-19

  Lee, Hsiang Kuang ^a   Driscoll, Deborah ^a   Asch, Harold ^a   Asch, Bonnie ^a   Zhang, Paul J ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b 6 Founders Pavilion ^*  (United States)

Author keywords

Benign prostatic hyperplasia; Gelsolin; Immunohistochemistry; Prostatic adenocarcinoma; Prostatic intraepithelial neoplasia

Indexed keywords

GELSOLIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CYTOSKELETON; DATA ANALYSIS; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; STATISTICAL ANALYSIS; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; DOWN-REGULATION; GELSOLIN; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033564171     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990615)40:1<14::AID-PROS2>3.0.CO;2-6     Document Type: Article

References (27)

1. Benjamin M, Archer CW, Ralphs JR. Cytoskeleton of cartilage cells. Microsc Res Tech 1994;28:372-377.
2. Stossel TP, Chaponnier C, Ezzell RM, Hartwig JH, Janmey PA, Kwiatkowski DJ, Lind SE, Smith DB, Southwick FS, Yin HL, Zaner KS. Nonmusde actin-binding proteins. Annu Rev Cell Biol 1985;1:353-402.
3. Pollard TD, Cooper JA. Actin and actin-binding proteins: a critical evaluation of mechanisms and functions. Annu Rev Biochem 1986;55:987-1035.
4. Holme TC, Kellie S, Wyke JA, Crawford N. Effect of transformation by Rous sarcoma virus on the character and distribution of actin in Rat-1 fibroblasts: a biochemical and microscopic study. Br J Cancer 1986;53:465-476.
5. Janmey PA, Chaponnier C. Medical aspects of the actin cytoskeleton. Curr Opin Cell Biol 1995;7:111-117.
6. Kwiatkowski DJ, Westbrook CA, Bruns GAP, Morton CC. Localization of gelsolin proximal to ABL on chromosome 9. Am J Hum Genet 1988;42:565-572.
7. Janmey PA, Stossel TP. Modulation of gelsolin function by phosphatidylinositol 4,5-biphosphate. Nature 1987;325:362-364.
8. Yin HL. Gelsolin: calcium- and polyphosphoinositide-regulated actin-modulating protein. BioEssays 1988;7:176-179.
9. Stossel TP. From signal to pseudopod. How cells control cytoplasmic actin assembly. J Biol Chem 1989;264:18261-18264.
10. Tanaka M, Mullauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T, Kuzumaki N. Gelsolin: a candidate for suppressor of human bladder cancer. Cancer Res 1995;55:3228-3232.
11. Chaponnier C, Gabbiani G. Gelsolin modulation in epithelial and stromal cells of mammary carcinoma. Am J Pathol 1989; 134:597-603.
12. Asch HL, Head K, Dong Y, Natoli F, Winston JS, Connolly JL, Asch BB. Widespread loss of gelsolin in breast cancers of human, mice, and rats. Cancer Res 1996;56:4841-4845.
13. Moriya S, Yanagihara K, Fujita H, Kuzumaki N. Differential expression of HSP90, gelsolin and GST in human gastric carcinoma cell lines. Int J Oncol 1994;5:1347-1351.
14. Afify AM, Werness BA. Decreased expression of actin-binding protein, gelsolin, in endometrial and ovarian adenocarcinoma. Appl Immunohistochem 1998;6:30-34.
15. Winston JS, Hicks W, Herr KD, Asch BB. Correlation of gelsolin and p53 expression with histologic features in squamous cell carcinoma of the head and neck [abstract]. Mod Pathol 1997;10: 118.
16. Porter RM, Holme TC, Newman EL, Hopwood D, Wilkinson JM, Cuschieri A. Monoclonal antibodies to cytoskeletal proteins: an immunohistochemical investigation of human colon cancer. J Pathol 1993;170:435-440.
17. Button E, Shapland C, Lawson D. Actin, its associated proteins and metastasis. Cell Motil Cytoskeleton 1995;30:247-251.
18. Renshaw AA, Chang H, D'Amico AV. Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice. Am J Clin Pathol 1997;107:704-708.
19. Bostwick DG. Neoplasms of the prostate. In: Bostwick DG, Eble JN, editors. Urologic surgical pathology. St. Louis: Mosby; 1997. p 343-421.
20. Kendall MG. Rank correlation methods, 4th ed. London: Griffin; 1970.
21. Iwig M, Czeslick E, Muller A, Gruner M, Spindler M, Glaesser D. Growth regulation by cell shape alteration and organization of the cytoskeleton. Eur J Cell Biol 1995;67:145-157.
22. Vandekerckhove J, Hauw G, Vancompernolle K, Honore B, Celis J. Comparative two-dimensional gel analysis and microsequencing identifies gelsolin as one of the most prominent down-regulated markers of transformed human fibroblast and epithelial cells. J Cell Biol 1990;111:95-102.
23. Bretscher A. Microfilaments and membranes. Curr Opin Cell Biol 1993;5:653-660.
24. Kroft SH, Oyasu R. Urinary bladder cancer: mechanisms of development and progression. Lab Invest 1994;71:158-174.
25. Linnenbach AJ, Pressier LB, Seng BA, Kimmel BS, Tomaszewski JE, Malkowicz SB. Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay. Hum Mol Genet 1993;9:1407-1411.
26. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE, Cordon-Cardo C. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumor. Cancer Res 1994;54:2848-2851.
27. Brandes D, Kirchein D, Scott WW. Ultrastructure of the human prostate. Normal and neoplastic. Lab Invest 1964;13:1541-1560.